Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer

Aim Several multigene expression-based tests offering prognostic and predictive information in hormone-receptor positive early breast cancer were established during the last years. These tests provide prognostic information on distant recurrences and can serve as an aid in therapy decisions. We anal...

Full description

Saved in:
Bibliographic Details
Main Authors: Varga, Zsuzsanna (Author) , Sinn, Peter (Author) , Fritzsche, Florian (Author) , Hochstetter, Arthur von (Author) , Noske, Aurelia (Author) , Schraml, Peter (Author) , Tausch, Christoph (Author) , Trojan, Andreas (Author) , Moch, Holger (Author)
Format: Article (Journal)
Language:English
Published: March 7, 2013
In: PLOS ONE
Year: 2013, Volume: 8, Issue: 3, Pages: 1-7
ISSN:1932-6203
DOI:10.1371/journal.pone.0058483
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0058483
Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058483
Get full text
Author Notes:Zsuzsanna Varga, Peter Sinn, Florian Fritzsche, Arthur von Hochstetter, Aurelia Noske, Peter Schraml, Christoph Tausch, Andreas Trojan, Holger Moch

MARC

LEADER 00000caa a2200000 c 4500
001 1793805725
003 DE-627
005 20220820134147.0
007 cr uuu---uuuuu
008 220224s2013 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0058483  |2 doi 
035 |a (DE-627)1793805725 
035 |a (DE-599)KXP1793805725 
035 |a (OCoLC)1341445402 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Varga, Zsuzsanna  |e VerfasserIn  |0 (DE-588)1134998198  |0 (DE-627)889959609  |0 (DE-576)489625703  |4 aut 
245 1 0 |a Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer  |c Zsuzsanna Varga, Peter Sinn, Florian Fritzsche, Arthur von Hochstetter, Aurelia Noske, Peter Schraml, Christoph Tausch, Andreas Trojan, Holger Moch 
264 1 |c March 7, 2013 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.02.2022 
520 |a Aim Several multigene expression-based tests offering prognostic and predictive information in hormone-receptor positive early breast cancer were established during the last years. These tests provide prognostic information on distant recurrences and can serve as an aid in therapy decisions. We analyzed the recently validated reverse-transcription-quantitative-real-time PCR-based multigene-expression Endopredict (EP)-test on 34 hormone-receptor positive breast-cancer cases and compared the EP scores with the Oncotype DX Recurrence-scores (RS) obtained from the same cancer samples. Methods Formalin-fixed, paraffin-embedded invasive breast-cancer tissues from 34 patients were analyzed by the EP-test. Representative tumor blocks were analyzed with Oncotype DX prior to this study. Tumor tissue was removed from unstained slides, total-RNA was isolated and EP-analysis was performed blinded to Oncotype DX results. Results Extraction of sufficient amounts of RNA and generation of valid EP-scores were possible for all 34 samples. EP classified 11 patients as low-risk and 23 patients as high-risk. RS Score defined 15 patients as low-risk, 10 patients as intermediate-risk in and 9 patients as high-risk. Major-discrepancy occurred in 6 of 34 cases (18%): Low-risk RS was classified as high-risk by EP in 6 cases. Combining the RS intermediate-risk and high-risk groups to a common group, the concordance between both tests was 76%. Correlation between continuous EP and RS-scores was moderate (Pearson-coefficient: 0.65 (p<0.01). Conclusion We observed a significant but moderate concordance (76%) and moderate correlation (0.65) between RS and EP Score. Differences in results can be explained by different weighting of biological motives covered by the two tests. Further studies are needed to explore the clinical relevance of discrepant test results with respect of outcome. 
650 4 |a Breast cancer 
650 4 |a Cancer chemotherapy 
650 4 |a Cancer risk factors 
650 4 |a Cancer treatment 
650 4 |a Colorectal cancer 
650 4 |a Fluorescent in situ hybridization 
650 4 |a Hormone bioassays 
650 4 |a Hormones 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Fritzsche, Florian  |e VerfasserIn  |4 aut 
700 1 |a Hochstetter, Arthur von  |e VerfasserIn  |4 aut 
700 1 |a Noske, Aurelia  |e VerfasserIn  |4 aut 
700 1 |a Schraml, Peter  |e VerfasserIn  |4 aut 
700 1 |a Tausch, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Trojan, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Moch, Holger  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 8(2013), 3, Artikel-ID e58483, Seite 1-7  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer 
773 1 8 |g volume:8  |g year:2013  |g number:3  |g elocationid:e58483  |g pages:1-7  |g extent:7  |a Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer 
856 4 0 |u https://doi.org/10.1371/journal.pone.0058483  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058483  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220224 
993 |a Article 
994 |a 2013 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |d 912000  |d 50000  |e 910000PS1022590944  |e 912000PS1022590944  |e 50000PS1022590944  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 2 
999 |a KXP-PPN1793805725  |e 4072060852 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"March 7, 2013"}],"relHost":[{"pubHistory":["1.2006 -"],"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"language":["eng"],"part":{"year":"2013","volume":"8","extent":"7","pages":"1-7","issue":"3","text":"8(2013), 3, Artikel-ID e58483, Seite 1-7"},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancerPLOS ONE","corporate":[{"role":"isb","display":"Public Library of Science"}],"recId":"523574592","name":{"displayForm":["Public Library of Science"]},"origin":[{"dateIssuedDisp":"2006-","publisher":"PLOS ; PLoS","publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedKey":"2006"}],"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2267670-3"],"eki":["523574592"],"issn":["1932-6203"]}}],"physDesc":[{"extent":"7 S."}],"id":{"doi":["10.1371/journal.pone.0058483"],"eki":["1793805725"]},"title":[{"title":"Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer","title_sort":"Comparison of Endopredict and Oncotype DX test results in hormone receptor positive invasive breast cancer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 24.02.2022"],"recId":"1793805725","person":[{"family":"Varga","role":"aut","display":"Varga, Zsuzsanna","given":"Zsuzsanna"},{"display":"Sinn, Peter","given":"Peter","role":"aut","family":"Sinn"},{"role":"aut","family":"Fritzsche","display":"Fritzsche, Florian","given":"Florian"},{"given":"Arthur von","display":"Hochstetter, Arthur von","role":"aut","family":"Hochstetter"},{"given":"Aurelia","display":"Noske, Aurelia","family":"Noske","role":"aut"},{"role":"aut","family":"Schraml","display":"Schraml, Peter","given":"Peter"},{"family":"Tausch","role":"aut","given":"Christoph","display":"Tausch, Christoph"},{"role":"aut","family":"Trojan","display":"Trojan, Andreas","given":"Andreas"},{"given":"Holger","display":"Moch, Holger","family":"Moch","role":"aut"}],"language":["eng"],"name":{"displayForm":["Zsuzsanna Varga, Peter Sinn, Florian Fritzsche, Arthur von Hochstetter, Aurelia Noske, Peter Schraml, Christoph Tausch, Andreas Trojan, Holger Moch"]}} 
SRT |a VARGAZSUZSCOMPARISON7201